Advertisement

Reference Safety Information Investigator Brochure

Reference Safety Information Investigator Brochure - This standard operating procedure (sop) describes the procedure for selecting and defining reference safety information (rsi) for assessing the expectedness of serious adverse. 2 which document should contain the reference safety information? The rsi is a list of expected serious adverse reactions, which are. The ib is a comprehensive document that includes the. The relationship with the imp is suspected by either investigator and sponsor. The rsi will usually be documented within the investigator’s brochure (ib). When submitting a clinical trial application the reference safety information (rsi) should be, when applicable, within the summary of product characteristics (smpc) or within the investigators. Recent eu national competent authority (nca) focus on clinical trial (ct) reference safety information (rsi) has resulted in an increase in rejections of investigator brochure (ib) updates. The rsi of an imp without marketing authorization (ma) in the eu should be a clearly separated specific section within. If the ib is not an smpc (summary of product characteristics), it shall contain a clearly identifiable section.

Sample Investigator's Brochure Template Free Download
FREE 10+ Investigator Brochure Templates in AI InDesign MS Word
Sample Investigator's Brochure Template Free Download
Clinical Investigator Brochure Template Medical Device Brochure Template
FREE 10+ Investigator Brochure Templates in AI InDesign MS Word
DSUR
Blank Investigator's Brochure Template Free Download
Blank Investigator's Brochure Template Free Download
FREE 10+ Investigator Brochure Templates in AI InDesign MS Word
Reference Safety Information in Clinical Trials Soterius

Related Post: